These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"]. Dávid M; Losonczy H; Udvardy M; Boda Z; Blaskó G; Tar A; Pfliegler G Orv Hetil; 2010 Aug; 151(34):1365-74. PubMed ID: 20705551 [TBL] [Abstract][Full Text] [Related]
12. IBD: which patients with IBD are at risk of venous thromboembolism? Koutroubakis IE Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):307-8. PubMed ID: 20523349 [No Abstract] [Full Text] [Related]
14. Risk of venous thromboembolism in patients with inflammatory bowel disease. Koutroumpakis EI; Tsiolakidou G; Koutroubakis IE Semin Thromb Hemost; 2013 Jul; 39(5):461-8. PubMed ID: 23629820 [TBL] [Abstract][Full Text] [Related]
15. Venous and arterial disease in inflammatory bowel disease. Tan VP; Chung A; Yan BP; Gibson PR J Gastroenterol Hepatol; 2013 Jul; 28(7):1095-113. PubMed ID: 23662785 [TBL] [Abstract][Full Text] [Related]
16. The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis. Khuwaja S; Kohn N; Sanghani SS; Khan S; Swaminath A; Sultan K Am J Ther; 2023 May; 30(3):e288-e291. PubMed ID: 37278710 [No Abstract] [Full Text] [Related]
17. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism risk in patients with inflammatory bowel disease: defining the benefits of pharmacologic prophylaxis. Sultan K; Brun A; Spyropoulos AC Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1577. PubMed ID: 24703865 [No Abstract] [Full Text] [Related]
19. Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease. Allen JI Dig Dis Sci; 2013 Jan; 58(1):1-4. PubMed ID: 23179161 [No Abstract] [Full Text] [Related]